Publications by authors named "Thomas C Shea"

83Publications

Collaborative care for depression and anxiety in the bone marrow transplant population: A pilot feasibility study.

Psychooncology 2020 Sep 2. Epub 2020 Sep 2.

Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.5541DOI Listing
September 2020

Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation.

Support Care Cancer 2020 Aug 23. Epub 2020 Aug 23.

Department of Psychiatry, University of North Carolina at Chapel Hill, 101 Manning Drive, Campus Box #7160, Chapel Hill, NC, 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-020-05697-2DOI Listing
August 2020

Design of a randomized placebo controlled trial of high dose intravenous thiamine for the prevention of delirium in allogeneic hematopoietic stem cell transplantation.

Contemp Clin Trials 2020 Aug 30;95:106076. Epub 2020 Jun 30.

Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2020.106076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492080PMC
August 2020

Evaluation of mobilization efficacy with an extended interval following plerixafor administration.

J Oncol Pharm Pract 2020 Oct 16;26(7):1590-1597. Epub 2020 Feb 16.

Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219900909DOI Listing
October 2020

Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplant.

Transpl Infect Dis 2019 Jun 26;21(3):e13091. Epub 2019 Apr 26.

Division of Infectious Diseases, University of North Carolina, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.13091DOI Listing
June 2019

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8177DOI Listing
December 2017

Are outcomes of allografts for CLL still relevant?

Authors:
Thomas C Shea

Blood 2017 09;130(12):1393-1394

UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-798561DOI Listing
September 2017

Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.

Leuk Lymphoma 2017 11 9;58(11):2573-2581. Epub 2017 Apr 9.

a Department of Medicine, Division of Hematology/Oncology , University of North Carolina , Chapel Hill , NC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1306644DOI Listing
November 2017

Chemotherapy and Stem Cell Transplantation Increase p16 Expression, a Biomarker of T-cell Aging.

EBioMedicine 2016 Sep 21;11:227-238. Epub 2016 Aug 21.

Department of Medicine, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, NC, USA; Department of Genetics, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964163037
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049997PMC
http://dx.doi.org/10.1016/j.ebiom.2016.08.029DOI Listing
September 2016

Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians.

Biol Blood Marrow Transplant 2016 11 29;22(11):2092-2099. Epub 2016 Jul 29.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067220PMC
http://dx.doi.org/10.1016/j.bbmt.2016.07.014DOI Listing
November 2016

Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North Carolina.

Cancer 2016 10 28;122(19):3041-50. Epub 2016 Jun 28.

Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30139DOI Listing
October 2016

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

J Clin Oncol 2015 Dec 2;33(35):4167-75. Epub 2015 Nov 2.

Steven M. Devine and William Blum, Ohio State University, Columbus, OH; Kouros Owzar, Flora Mulkey, Vera Hars, and Alexander B. Sibley, Alliance Statistics and Data Center, Duke University, Durham; Thomas C. Shea, University of North Carolina, Chapel Hill, NC; Richard M. Stone, Robert J. Soiffer, and Edwin P. Alyea, Dana-Farber Cancer Institute; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Jack W. Hsu, University of Florida, Gainesville, FL; Richard E. Champlin, MD Anderson Cancer Research Center, Houston, TX; Ravi Vij, Washington University, St. Louis, MO; James Slack, Mayo Clinic, Scottsdale, AZ; Richard A. Larson, University of Chicago, Chicago, IL; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Shelly Carter, The EMMES Corporation, Bethesda, MD; Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; and Charles Linker, University of California at San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.7273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658453PMC
December 2015

Coma associated with nelarabine in an elderly patient with T-cell acute lymphoblastic leukemia and severe chronic renal disease.

Leuk Lymphoma 2016 8;57(4):957-60. Epub 2015 Oct 8.

a UNC Lineberger Comprehensive Cancer Center , Chapel Hill , NC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1083096DOI Listing
December 2016

Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients.

Biol Blood Marrow Transplant 2015 Dec 22;21(12):2129-2135. Epub 2015 Jul 22.

Program in Bone Marrow and Stem Cell Transplantation, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150047
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.07.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639403PMC
December 2015

Concurrent Disseminated Nocardiosis and GI Mucormycosis in a Stem-Cell Transplantation Recipient.

J Clin Oncol 2016 Apr 28;34(10):e84-6. Epub 2014 Jul 28.

University of North Carolina, Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4042DOI Listing
April 2016

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.

N Engl J Med 2013 Oct;369(18):1681-90

From Loyola University Medical Center, Maywood, IL (P.J.S., K.P.B.); Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle (J.M.U., M.L.); Cleveland Clinic, Cleveland (J.R.C., R.R.T.); University of Rochester, Rochester, NY (L.S.C., J.W.F., R.I.F.); Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS (S.C.), University of Calgary-Tom Baker Cancer Centre, Calgary, AB (D.A.S.), and Margaret and Charles Juravinski Cancer Centre, Hamilton, ON (D.M.) - all in Canada; University of North Carolina at Chapel Hill, Chapel Hill (T.C.S.); Ohio State University Medical Center, Columbus (P.P.); Northwestern University, Chicago (J.N.W.); University of Wisconsin, Madison (B.S.K.); University of Arizona, Tucson (T.P.M., L.M.R.); Louisiana State University Health Sciences Center, Shreveport (G.M.M.); City of Hope Medical Center, Duarte, CA (S.J.F.); and Fox Chase Cancer Center-Temple Health, Temple University School of Medicine, Philadelphia (R.I.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1301077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985418PMC
October 2013

Controversies in BMT for lymphoma.

Biol Blood Marrow Transplant 2013 Jan 23;19(1 Suppl):S26-32. Epub 2012 Oct 23.

British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.10.024DOI Listing
January 2013

Second transplants for NHL: if at first you don't succeed….

Authors:
Thomas C Shea

Biol Blood Marrow Transplant 2012 Aug 4;18(8):1148-9. Epub 2012 Jul 4.

UNC Lineberger Comprehensive Cancer Center and Department of Medicine, University of North Carolina at Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.05.018DOI Listing
August 2012

Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development.

Biol Blood Marrow Transplant 2012 Jun 20;18(6):968-73. Epub 2012 Mar 20.

Department of Pathology and Laboratory Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.03.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693471PMC
June 2012

Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.

Cancer Invest 2011 Mar;29(3):214-9

Division of Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357907.2010.550663DOI Listing
March 2011

Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.

J Mol Diagn 2010 Jan 3;12(1):3-16. Epub 2009 Dec 3.

Department of Pathology and Laboratory Medicine, 913 Brinkhous-Bullitt Building, University of North Carolina, Chapel Hill, NC 27599-7525, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/jmoldx.2010.090054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797712PMC
January 2010

Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.

Nucl Med Commun 2009 Aug;30(8):594-601

Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0b013e32832cc295DOI Listing
August 2009

Cancer clinical trials in North Carolina.

N C Med J 2008 Jul-Aug;69(4):306-8

Moses Cone Regional Cancer Center, USA.

View Article

Download full-text PDF

Source
November 2008

The effect of palifermin on chemotherapyand radiation therapy-induced mucositis: a review of the current literature.

Support Cancer Ther 2007 Sep;4(4):188-97

Division of Oncology, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/SCT.2007.n.014DOI Listing
September 2007

Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.

Drugs Today (Barc) 2007 Jul;43(7):461-73

Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1358/dot.2007.43.7.1119723DOI Listing
July 2007

Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignancies.

Expert Opin Pharmacother 2006 Nov;7(16):2287-99

University of North Carolina, Hematology/Oncology, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.7.16.2287DOI Listing
November 2006

Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies.

Biol Blood Marrow Transplant 2005 Dec;11(12):1022-30

Division of Hematology/Oncology, Bone Marrow Transplant Program, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2005.08.033DOI Listing
December 2005

Transfusion medicine illustrated. G-CSF-associated rash in an allogeneic PBPC donor.

Transfusion 2003 Oct;43(10):1343

University of North Carolina Hospitals, Transfusion Medicine Services, Chapel Hill, North Carolina 27514-4216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1537-2995.2003.00511.xDOI Listing
October 2003

An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.

Biol Blood Marrow Transplant 2003 Jul;9(7):443-52

Division of Medical Oncology, Campus Box #7305, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1083-8791(03)00204-0DOI Listing
July 2003

Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia.

Am J Hematol 2002 Nov;71(3):184-90

Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Rm. 3009 Old Clinic Building, Chapel Hill, NC 27599-7305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.10215DOI Listing
November 2002